Jefferies analyst Michael Yee maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $350.00. The company’s ...

AI is a big part of AMD, but the company's AI-market share remained significantly lower than that of Nvidia, which dominates ...

BSE stock price has rallied 20% in three months and has delivered multibagger returns of more than 150% in one year. The ...

The dollar weakened against the euro on Tuesday but stayed near its highest level in more than two years as ...

Jefferies analyst Surinder Thind raised the firm’s price target on FICO (FICO) to $2,275 from $2,250 and keeps a Buy rating on the shares. Among ...

Find insight on Pro Medicus, WELL Health Technologies and more in the latest Market Talks covering the Health Care sector.

Investing.com -- ASOS (LON: ASOS) on Wednesday announced plans to mothball its Atlanta distribution center in the second half ...

JPM25 is in full swing as several pharma powerhouses—including Merck, Lilly and Amgen—detail their strategies for growth in ...

Jefferies analyst Blayne Curtis remains bullish on Broadcom and Marvell. He expects AVGO and MRVL to benefit from demand for custom AI chips.

Q3 is expected to be a weak quarter for lenders, including Axis Bank, as the sector continues to grapple with challenges such ...

HDFC AMC shares climb 5% on Q3 profit surge; brokerages maintain positive ratings. Explore market trends and stock forecasts!

Shares in Cellnex rose after the Spanish telecommunications-infrastructure company said it would launch a share-buyback program of up to 800 million euros ($824.7 million) during the first quarter.